Richard Thomas Menziuso
CIK: 0002156820
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALT
Altimmune, Inc.
Officer
Discretionary Trading P&L
Holdings
About MENZIUSO RICHARD THOMAS
MENZIUSO RICHARD THOMAS (SEC CIK 0002156820) files insider reports with the SEC as Principal Accounting Officer of Altimmune, Inc. (ALT).
Signal8 holds 2 ownership filings by MENZIUSO RICHARD THOMAS (1 Form 3, 1 Form 4), filed on Oct 2, 2026. Those filings report 2 transactions, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MENZIUSO RICHARD THOMAS's filings is in GAITHERSBURG, MD.
Recent filings by MENZIUSO RICHARD THOMAS
- Oct 1, 2026: Grants or awards of ALT derivative securities (2 lines, Form 4, code A).
Other insiders filing for Altimmune, Inc. (ALT)
- Arbet-Engels Christophe, Chief Medical Officer
- WEAVER GREGORY L, Chief Financial Officer
- Richardson Linda M, Chief Commercial Officer
- Durso Jerome Benedict, President and CEO
- Roberts M Scot, Chief Scientific Officer
- Lawver Teri L, Director